Literature DB >> 12439168

Measuring comorbidity in patients with head and neck cancer.

Stephen F Hall1, Paula A Rochon, David L Streiner, Lawrence F Paszat, Patti A Groome, Susan L Rohland.   

Abstract

BACKGROUND: Comorbidities are diseases or conditions that coexist with a disease of interest. The importance of comorbidities is that they can alter treatment decisions, change resource utilization, and confound the results of survival analysis.
OBJECTIVE: The objective of this study was to determine the best comorbidity index to use in survival analysis of patients with squamous cell carcinoma of the head and neck.
METHOD: Four validated indexes, with very different methodologies (i.e., the Charlson Index, the Cumulative Illness Rating Scale, the Kaplan-Feinstein Classification, the Index of Co-existent Disease), were tested using data from 379 unselected consecutive patients with complete 3-year follow-up from the Kingston Regional Cancer Center. Kaplan-Meier analysis and Cox Proportional Hazards Regression were used to stratify patients into three levels of increasing severity of comorbidity for each index. The Proportion of Variance Explained and Receiver Operating Characteristics curves were used to compare the performance of the indexes.
CONCLUSION: The Kaplan-Feinstein Classification was the most successful in stratifying patients in this population.

Entities:  

Mesh:

Year:  2002        PMID: 12439168     DOI: 10.1097/00005537-200211000-00015

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  9 in total

1.  Mechanisms of decision-making in preoperative assessment for older adult prostate cancer patients-A qualitative study.

Authors:  Patrick Kierkegaard; Mira D Vale; Spencer Garrison; Brent K Hollenbeck; John M Hollingsworth; Jason Owen-Smith
Journal:  J Surg Oncol       Date:  2019-12-23       Impact factor: 3.454

2.  Survival of patients with head and neck cancer. Impact of physical status and comorbidities.

Authors:  F Sadat; A Wienke; J Dunst; T Kuhnt
Journal:  Strahlenther Onkol       Date:  2011-12-23       Impact factor: 3.621

Review 3.  Comorbidity in older adults with cancer.

Authors:  Grant R Williams; Amy Mackenzie; Allison Magnuson; Rebecca Olin; Andrew Chapman; Supriya Mohile; Heather Allore; Mark R Somerfield; Valerie Targia; Martine Extermann; Harvey Jay Cohen; Arti Hurria; Holly Holmes
Journal:  J Geriatr Oncol       Date:  2015-12-22       Impact factor: 3.599

4.  Morphomic analysis as an aid for preoperative risk stratification in patients undergoing major head and neck cancer surgery.

Authors:  Jacob Rinkinen; Shailesh Agarwal; Jeff Beauregard; Oluseyi Aliu; Matthew Benedict; Steven R Buchman; Stewart C Wang; Benjamin Levi
Journal:  J Surg Res       Date:  2014-10-07       Impact factor: 2.192

5.  Treatment Outcomes of Sinonasal Malignancies Involving the Orbit.

Authors:  Chul Ho Shin; Ho Jun Lee; Yoo-Sam Chung; Ji Heui Kim
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-29

Review 6.  An electronic application for rapidly calculating Charlson comorbidity score.

Authors:  William H Hall; Ramanathan Ramachandran; Samir Narayan; Ashesh B Jani; Srinivasan Vijayakumar
Journal:  BMC Cancer       Date:  2004-12-20       Impact factor: 4.430

7.  comoR: a software for disease comorbidity risk assessment.

Authors:  Mohammad Ali Moni; Pietro Liò
Journal:  J Clin Bioinforma       Date:  2014-05-23

8.  The impact of comorbidity on overall survival in elderly nasopharyngeal carcinoma patients: a National Cancer Data Base analysis.

Authors:  Ying Huang; Wei Chen; Waqar Haque; Vivek Verma; Yan Xing; Bin S Teh; Edward Brian Butler
Journal:  Cancer Med       Date:  2018-03-01       Impact factor: 4.452

9.  How to Improve the Drafting of Health Profiles.

Authors:  Margherita Napolitani; Giovanni Guarducci; Gulnara Abinova; Gabriele Messina; Nicola Nante
Journal:  Int J Environ Res Public Health       Date:  2022-03-15       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.